275 related articles for article (PubMed ID: 20688878)
1. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
[TBL] [Abstract][Full Text] [Related]
2. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells.
Lin CC; Chiang LL; Lin CH; Shih CH; Liao YT; Hsu MJ; Chen BC
Eur J Pharmacol; 2007 Apr; 560(2-3):101-9. PubMed ID: 17307160
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
[TBL] [Abstract][Full Text] [Related]
5. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells.
Fong YC; Hsu SF; Wu CL; Li TM; Kao ST; Tsai FJ; Chen WC; Liu SC; Wu CM; Tang CH
Lung Cancer; 2009 Apr; 64(1):13-21. PubMed ID: 18771813
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
Bendinelli P; Matteucci E; Maroni P; Desiderio MA
Mol Cancer Res; 2009 Aug; 7(8):1328-41. PubMed ID: 19671685
[TBL] [Abstract][Full Text] [Related]
9. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
10. Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.
Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH
Mol Cancer Res; 2013 Oct; 11(10):1279-91. PubMed ID: 23858099
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
[TBL] [Abstract][Full Text] [Related]
12. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CK2 activity by TGF-beta1 promotes IkappaB-alpha protein stabilization and apoptosis of immortalized hepatocytes.
Cavin LG; Romieu-Mourez R; Panta GR; Sun J; Factor VM; Thorgeirsson SS; Sonenshein GE; Arsura M
Hepatology; 2003 Dec; 38(6):1540-51. PubMed ID: 14647065
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR
Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast-derived TGF-beta1 stimulates IL-8 release through AP-1 and NF-kappaB in human cancer cells.
Fong YC; Maa MC; Tsai FJ; Chen WC; Lin JG; Jeng LB; Yang RS; Fu WM; Tang CH
J Bone Miner Res; 2008 Jun; 23(6):961-70. PubMed ID: 18435575
[TBL] [Abstract][Full Text] [Related]
17. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
19. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.
Monteleone G; Mann J; Monteleone I; Vavassori P; Bremner R; Fantini M; Del Vecchio Blanco G; Tersigni R; Alessandroni L; Mann D; Pallone F; MacDonald TT
J Biol Chem; 2004 Feb; 279(6):3925-32. PubMed ID: 14600158
[TBL] [Abstract][Full Text] [Related]
20. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]